Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Tumor Suppressor Genes. Found 37 abstracts

no pagination
Dasgupta Y, Koptyra M, Hoser G, Kantekure K, Roy D, Gornicka B, Nieborowska-Skorska M, Bolton-Gillespie E, Cerny-Reiterer S, Muschen M, Valent P, Wasik MA, Richardson C, Hantschel O, van der Kuip H, Stoklosa T, Skorski T. Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases. Blood. 2016 Apr 28;127(17):2131-43.   PMCID: PMC4850868
Menges CW, Kadariya Y, Altomare D, Talarchek J, Neumann-Domer E, Wu Y, Xiao GH, Shapiro IM, Kolev VN, Pachter JA, Klein-Szanto AJ, Testa JR. Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. Cancer Res. 2014 Feb 15;74(4):1261-71.   PMCID: PMC3945416
Hoffman AM, Cairns P. Epigenetics of kidney cancer and bladder cancer. Epigenomics. 2011 Feb;3(1):19-34.   PMCID: PMC3314381
Enders GH. Wnt therapy for bone loss: golden goose or Trojan horse?. J Clin Invest. 2009 Apr;119(4):758-60.   PMCID: PMC2662580
Nunez MI, Rosen DG, Ludes-Meyers JH, Abba MC, Kil H, Page R, Klein-Szanto AJ, Godwin AK, Liu J, Mills GB, Aldaz CM. WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome. BMC cancer. 2005 Jan;5(1):64.
Cairns P. Detection of promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Ann N Y Acad Sci. 2004 Jun;1022:40-3.
Cvetkovic D, Pisarcik D, Lee C, Hamilton TC, Abdollahi A. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer. Gynecologic Oncology. 2004 Dec;95(3):449-55.
Balkwill F, Bast RC, Berek J, Chenevix-Trench G, Gore M, Hamilton T, Jacobs I, Mills G, Souhami R, Urban N, Ursulic S, Smyth J. Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust. Eur J Cancer. 2003 Sep;39(13):1818-27.
Biade S, Murphy ME. Differential display techniques to identify tumor suppressor gene pathways. Methods Mol Biol. 2003 Jan;222:481-90.
Astrinidis A, Cash TP, Hunter DS, Walker CL, Chernoff J, Henske EP. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration. Oncogene. 2002 Dec 05;21(55):8470-6.
Calvert PM, Frucht H. The genetics of colorectal cancer. Annals of internal medicine. 2002 Oct;137(7):603-12.
Capo-Chichi CD, Smith ER, Yang DH, Roland IH, Vanderveer L, Cohen C, Hamilton TC, Godwin AK, Xu XX. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis. Cancer. 2002 Oct 15;95(8):1802-15.
Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin Oncol. 2002 Feb;29(1):2-17.
Christopher SA, Diegelman P, Porter CW, Kruger WD. Methylthioadenosine Phosphorylase, a Gene Frequently Codeleted with p16(cdkN2a/ARF), Acts as a Tumor Suppressor in a Breast Cancer Cell Line. Cancer Res. 2002 Nov 15;62(22):6639-44.
Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, Feliciano CS, Gartel A, Hay N. Activation of Akt/protein kinase B overcomes a G(2)/m cell cycle checkpoint induced by DNA damage. Mol Cell Biol. 2002 Nov;22(22):7831-41.
Knudson AG. Cancer genetics. Am J Med Genet. 2002 Jul 22;111(1):96-102.
Prowse AH, Vanderveer L, Milling SW, Pan ZZ, Dunbrack RL, Xu XX, Godwin AK. OVCA2 is downregulated and degraded during retinoid-induced apoptosis. International journal of cancer. 2002 May 10;99(2):185-92.
Yang DH, Smith ER, Cohen C, Wu H, Patriotis C, Godwin AK, Hamilton TC, Xu XX. Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity. Cancer. 2002 May;94(9):2380-92.
Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, Pandolfi PP. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nature genetics. 2001 Feb;27(2):222-4.
Esteller M, Fraga MF, Guo M, Garcia-Foncillas J, Hedenfalk I, Godwin AK, Trojan J, Vaurs-Barriere C, Bignon YJ, Ramus S, Benitez J, Caldes T, Akiyama Y, Yuasa Y, Launonen V, Canal MJ, Rodriguez R, Capella G, Peinado MA, Borg A, Aaltonen LA, Ponder BA, Baylin SB, Herman JG. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Human molecular genetics. 2001 Dec 15;10(26):3001-7.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Tumor Suppressor Genes

Tumor Suppressor Genes genetics Human US Gov't Support-PHS metabolism physiology Non-US Gov't Support Female Ovarian Neoplasms Mice pathology Cultured Tumor Cells Mutation Proteins Animal Signal Transduction analysis Protein p53 Neoplastic Gene Expression Regulation Breast Neoplasms Apoptosis Immunohistochemistry Tumor Suppressor Proteins DNA Methylation physiopathology pharmacology Oncogenes diagnosis Biological Models MicroRNAs enzymology Promoter Regions (Genetics) therapy Rats Repressor Proteins Genetic Predisposition to Disease etiology Male SCID Mice biosynthesis Phosphoric Monoester Hydrolases Messenger RNA drug effects Laminin Basement Membrane Neoplastic Cell Transformation methods chemistry Pleural Neoplasms Cell Division DNA Repair Neoplastic Stem Cells Kidney Neoplasms Cell Line Asbestos US Gov't Support-Non-PHS Gene Expression therapeutic use Gene Deletion Loss of Heterozygosity Adult Antineoplastic Agents Mesothelioma Hereditary Neoplastic Syndromes Transfection epidemiology Cell Cycle Complementary DNA Ovary Hereditary Nonpolyposis Colorectal Neoplasms Signal Transducing Adaptor Proteins Proto-Oncogene Proteins c-abl Nuclear Proteins Experimental Leukemia Enzyme Activation Osteosarcoma human) 0 (PLAGL1 protein Western Blotting Middle Age Collagen Type IV Gene Expression Profiling Genetic Screening RNA Tretinoin CDC2 Protein Kinase rho GTP-Binding Proteins Recombinant Fusion Proteins Molecular Models Oxidoreductases Tumor Virus Infections Non-US Gov't Research Support COS Cells Retinoids Gamma Rays Oligonucleotide Array Sequence Analysis Fenretinide Oxidative Stress p53 Genes Animal Disease Models deficiency Cell Adhesion Pyridazines Proto-Oncogene Proteins c-bcl-2 Tuberous Sclerosis Prostatic Neoplasms Molecular Evolution Occupational Exposure Histones Progesterone Receptors Reverse Transcriptase Polymerase Chain Reaction Imidazoles Gene Silencing Treatment Outcome Amino Acid Sequence Simian virus 40 Adenomatous Polyposis Coli Colonic Neoplasms Randomized Controlled Trials ge [Genetics] Urinary Bladder Neoplasms 0 (Transcription Factors) Pedigree Cell Cycle Proteins cdc Genes Human Chromosomes-Pair 6 Adolescent Putrescine abl Genes Mutant Strains Mice Genetic Counseling CpG Islands Neoplasm DNA radiation effects Protein Kinase Inhibitors chemical synthesis Northern Blotting BRCA2 Genes Promyelocytic Leukemia-Acute Genomic Instability Polymerase Chain Reaction BRCA1 Genes Turkey Proto-Oncogene Proteins c-myc urine Hela Cells Biogenic Polyamines Polymorphism (Genetics) Neoplasm Proteins Gene Expression Regulation Blast Crisis
Last updated on Wednesday, February 05, 2020